Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Renal disease in tuberous sclerosis complex: pathogenesis and therapy.

Lam HC, Siroky BJ, Henske EP.

Nat Rev Nephrol. 2018 Nov;14(11):704-716. doi: 10.1038/s41581-018-0059-6. Review.

PMID:
30232410
2.

Pulmonary manifestations in tuberous sclerosis complex.

Gupta N, Henske EP.

Am J Med Genet C Semin Med Genet. 2018 Sep;178(3):326-337. doi: 10.1002/ajmg.c.31638. Epub 2018 Jul 28. Review.

PMID:
30055039
3.

Familial pneumothorax: towards precision medicine.

Scott RM, Henske EP, Raby B, Boone PM, Rusk RA, Marciniak SJ.

Thorax. 2018 Mar;73(3):270-276. doi: 10.1136/thoraxjnl-2017-211169. Epub 2017 Dec 28. Review.

PMID:
29288214
4.

The effect of mTOR inhibitors on respiratory infections in lymphangioleiomyomatosis.

Courtwright AM, Goldberg HJ, Henske EP, El-Chemaly S.

Eur Respir Rev. 2017 Jan 17;26(143). pii: 160004. doi: 10.1183/16000617.0004-2016. Print 2017 Jan. Review.

5.

New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex.

Lam HC, Nijmeh J, Henske EP.

J Pathol. 2017 Jan;241(2):219-225. doi: 10.1002/path.4827. Epub 2016 Nov 29. Review.

6.

Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference.

Sahin M, Henske EP, Manning BD, Ess KC, Bissler JJ, Klann E, Kwiatkowski DJ, Roberds SL, Silva AJ, Hillaire-Clarke CS, Young LR, Zervas M, Mamounas LA; Tuberous Sclerosis Complex Working Group to Update the Research Plan.

Pediatr Neurol. 2016 Jul;60:1-12. doi: 10.1016/j.pediatrneurol.2016.03.015. Epub 2016 Apr 2.

7.

Tuberous sclerosis complex.

Henske EP, Jóźwiak S, Kingswood JC, Sampson JR, Thiele EA.

Nat Rev Dis Primers. 2016 May 26;2:16035. doi: 10.1038/nrdp.2016.35. Review.

PMID:
27226234
8.

Mechanisms of pulmonary cyst pathogenesis in Birt-Hogg-Dube syndrome: The stretch hypothesis.

Kennedy JC, Khabibullin D, Henske EP.

Semin Cell Dev Biol. 2016 Apr;52:47-52. doi: 10.1016/j.semcdb.2016.02.014. Epub 2016 Feb 10. Review.

PMID:
26877139
9.

The next breakthrough in LAM clinical trials may be their design: challenges in design and execution of future LAM clinical trials.

El-Chemaly S, Henske EP.

Expert Rev Respir Med. 2015 Apr;9(2):195-204. doi: 10.1586/17476348.2015.1024663. Epub 2015 Mar 10. Review.

PMID:
25757365
10.

Therapeutic targeting of cellular metabolism in cells with hyperactive mTORC1: a paradigm shift.

Medvetz D, Priolo C, Henske EP.

Mol Cancer Res. 2015 Jan;13(1):3-8. doi: 10.1158/1541-7786.MCR-14-0343. Epub 2014 Oct 8. Review.

11.

Kinase mTOR: regulation and role in maintenance of cellular homeostasis, tumor development, and aging.

Parkhitko AA, Favorova OO, Khabibullin DI, Anisimov VN, Henske EP.

Biochemistry (Mosc). 2014 Feb;79(2):88-101. doi: 10.1134/S0006297914020023. Review.

PMID:
24794724
12.

Towards personalised therapy for lymphangioleiomyomatosis: lessons from cancer.

El-Chemaly S, Henske EP.

Eur Respir Rev. 2014 Mar 1;23(131):30-5. doi: 10.1183/09059180.00008813. Review.

13.

Autophagy: mechanisms, regulation, and its role in tumorigenesis.

Parkhitko AA, Favorova OO, Henske EP.

Biochemistry (Mosc). 2013 Apr;78(4):355-67. doi: 10.1134/S0006297913040044. Review.

PMID:
23590438
14.

Lymphangioleiomyomatosis - a wolf in sheep's clothing.

Henske EP, McCormack FX.

J Clin Invest. 2012 Nov;122(11):3807-16. doi: 10.1172/JCI58709. Epub 2012 Nov 1. Review.

15.

Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis.

Neuman NA, Henske EP.

EMBO Mol Med. 2011 Apr;3(4):189-200. doi: 10.1002/emmm.201100131. Epub 2011 Mar 16. Review.

16.

Mammalian target of rapamycin signaling and autophagy: roles in lymphangioleiomyomatosis therapy.

Yu J, Parkhitko AA, Henske EP.

Proc Am Thorac Soc. 2010 Feb;7(1):48-53. doi: 10.1513/pats.200909-104JS. Review.

17.

Analysis of published PKD1 gene sequence variants.

Gout AM; ADPKD Gene Variant Consortium, Ravine D, Harris PC, Rossetti S, Peters D, Breuning M, Henske EP, Koizumi A, Inoue S, Shimizu Y, Thongnoppakhun W, Yenchitsomanus PT, Deltas C, Sandford R, Torra R, Turco AE, Jeffery S, Fontes M, Somlo S, Furu LM, Smulders YM, Mercier B, Ferec C, Burtey S, Pei Y, Kalaydjieva L, Bogdanova N, McCluskey M, Geon LJ, Wouters CH, Reiterova J, Stekrová J, San Millan JL, Aguiari G, Del Senno L.

Nat Genet. 2007 Apr;39(4):427-8. Review. No abstract available.

PMID:
17392796
18.

The tuberous sclerosis complex.

Crino PB, Nathanson KL, Henske EP.

N Engl J Med. 2006 Sep 28;355(13):1345-56. Review. No abstract available.

PMID:
17005952
19.

The role of tuberin in cellular differentiation: are B-Raf and MAPK involved?

Karbowniczek M, Henske EP.

Ann N Y Acad Sci. 2005 Nov;1059:168-73. Review.

PMID:
16382052
20.

Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.

Astrinidis A, Henske EP.

Oncogene. 2005 Nov 14;24(50):7475-81. Review.

PMID:
16288294

Supplemental Content

Loading ...
Support Center